Judge dismisses Seroquel product liability suits
Executive Summary
A judge threw out two lawsuits claiming AstraZeneca failed to provide adequate warning that its atypical antipsychotic Seroquel (quetiapine) increased the risk of diabetes. The suits, brought by Anne Guinn and David Haller, are among more than 7,000 pending in multidistrict litigation in the U.S. District Court of the Middle District of Florida. They were selected as test cases for trial and, on Jan. 30, U.S. District Judge Anne Conway granted AstraZeneca's motion for summary judgment in both. In the Guinn case she ruled that there is "no evidence in the record from which a reasonable juror could conclude that Seroquel contributed substantially to producing Guinn's injury.